MELISSA REDDING: Open Payments
NPI 1831588623 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$566 in 21 payments from 13 companies in 2025. Trend: 2023 $622 · 2024 $1,533 · 2025 $566
Food & beverage: $566
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. | 1 | $134 |
| Amgen Inc. | 3 | $73 |
| Pharmacosmos Therapeutics Inc. | 2 | $53 |
| Otsuka America Pharmaceutical, Inc. | 2 | $52 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Ardelyx, Inc. | 2 | $32 |
| Daiichi Sankyo Inc. | 1 | $27 |
| Aurinia Pharma U.S., Inc. | 1 | $24 |
Products named: Filspari, KRYSTEXXA, MONOFERRIC, Kerendia, JARDIANCE, FARXIGA, IBSRELA, INJECTAFER.
Industry payments across OK — which companies pay providers there.
